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Eukaryotic cells contain hundreds of proteins that require iron cofactors for activity. These
iron enzymes are located in essentially every subcellular compartment; thus, iron cofactors
must travel to every compartment in the cell. Iron cofactors exist in three basic forms:
Heme, iron–sulfur clusters, and simple iron ions (also called non-heme iron). Iron ions taken
up by the cell initially enter a kinetically labile, exchangeable pool that is referred to as the
labile iron pool. The majority of the iron in this pool is delivered to mitochondria, where it is
incorporated into heme and iron–sulfur clusters, as well as non-heme iron enzymes.These
cofactors must then be distributed to nascent proteins in the mitochondria, cytosol, and
membrane-bound organelles. Emerging evidence suggests that speciﬁc systems exist
for the distribution of iron cofactors within the cell. These systems include membrane
transporters, protein chaperones, specialized carriers, and small molecules. This review
focuses on the distribution of iron ions in the cytosol and will highlight differences between
the iron distribution systems of simple eukaryotes and mammalian cells.
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One of the most important concepts to emerge from the ﬁeld of
eukaryotic cell biology is that the contents of the cell are highly
organized and the movement of organelles and macromolecules
within the cell does not occur through simple diffusion.Movement
is highly regulated through packaging and assembly of complexes
and through directed transport via components of the cytoskele-
ton. Cells express hundreds, perhaps thousands of proteins that
require bound metal cofactors for activity and stability (Waldron
et al., 2009). Iron and zinc are the most abundant metals in cells,
followed by copper and manganese, and, to a lesser extent, cobalt,
nickel, and molybdenum. Thus, it is not surprising to discover
the existence of intracellular systems for the distribution of met-
als and metal cofactors. Why do cells need these metal delivery
systems? It is because the cell faces several obstacles in achiev-
ing the two major goals of metal cofactor delivery, which are
incorporation of the native cofactor and exclusion of non-native
cofactors.
A major obstacle to acquisition of metal cofactors by apoen-
zymes is that thebinding sites for these cofactors frequently lack the
capacity to discriminate between different divalent metal cations
and cofactors (Kasampalidis et al., 2007; Waldron et al., 2009).
The sulfur, oxygen, and nitrogen ligands that coordinate met-
als in enzymes will frequently bind non-native cofactors with
afﬁnities equal to or greater than those of the native cofac-
tor. A second obstacle is that redox-active metals, such as iron,
copper, and manganese can engage in Fenton-type chemistry
in the presence of oxygen and produce potentially damaging
reactive oxygen species. Thus, cells must tightly regulate the
uptake, storage, and distribution of metal ion species. A third
obstacle is that zinc and copper ions exhibit the highest afﬁn-
ity for transition metal-binding sites and would occupy iron and
manganese sites if the metals were present in freely exchange-
able pools of similar concentrations (Irving and Williams, 1953).
Consequently, cells maintain pools of zinc and copper at exceed-
ingly low levels (Rae et al., 1999; Outten and O’Halloran,
2001). This is accomplished through tightly regulated uptake
and efﬂux and through the expression of metal-binding pro-
teins, such as metallothioneins, that effectively sequester pools
of zinc and copper. Iron, however, appears to be managed
differently.
THE FATE OF INTRACELLULAR IRON
In mammals, iron enters the cell through a variety of transport
systems, including the endosomal transporter DMT1 (Figure 1)
(reviewed in Shawki et al., 2012), which receives transferrin-
bound iron, and Zip14, which can take up both endosomal
transferrin- and extracellular non-transferrin-bound iron (Liuzzi
et al., 2006; Zhao et al., 2010). The majority of iron taken up
throughmembrane transporters enters ametabolically active pool
in the cytosol (Shvartsman and Ioav Cabantchik, 2012), although
a small amount may be transferred directly from endosomes to
mitochondria (Sheftel et al., 2007). The molecular nature of this
cytosolic pool is largely unknown, but operationally it is deﬁned as
the freely exchangeable iron that is loosely coordinated by water,
small molecules, and proteins, and has been termed the labile
iron pool (LIP). Most of the iron entering the LIP is directed to
mitochondria (Shvartsman and Ioav Cabantchik, 2012), where it
can be incorporated into mononuclear or dinuclear iron centers,
inserted into protoporphyrin IX to form heme, or used in the
assembly of iron–sulfur clusters. Mitochondrial heme and iron–
sulfur clusters are bound by enzymes within mitochondria, but
heme and some product of the Fe–S cluster assembly machinery
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FIGURE 1 | Distribution of iron in the cytosol of mammalian cells.
Iron enters the cytosolic labile iron pool (LIP) as Fe(II) and may be
coordinated by reduced glutathione (GSH). Most of the iron entering the
LIP is delivered to mitochondria for the synthesis of heme and Fe–S
clusters. In the cytosol, homodimers of Grx3 or heterooligomers of Grx3
and BolA2 coordinate [2Fe-2S] clusters with the help of GSH. These
clusters may be used for the metallation of cytosolic Fe-S enzymes (via
the cytosolic iron–sulfur cluster assembly machinery, CIA) and may have a
role in mitochondrial iron delivery in erythroid tissues. PCBP1 and PCBP2
bind iron in the cytosol and deliver it to target non-heme iron enzymes,
such as ferritin, 2-oxoglutarate-dependent dioxygenases (mononuclear iron
enzymes such as PHD2 or FiH1), and oxo- or peroxo-bridged diiron
oxygenases (dinuclear iron enzymes such as DOHH). The source of iron
for PCBPs is not known, but could include components of the LIP
coordinated by GSH or iron coordinated by Grx3. PCBP2 may directly
acquire iron from transporters such as DMT1 and may also deliver iron to
ferroportin for efﬂux. Some intracellular organelles have been omitted for
clarity. Red spheres indicate inorganic sulﬁde as part of an Fe–S cluster.
are also exported frommitochondria for utilization in the cytosol,
nucleus, and other membrane-bound organelles. Cytosolic iron
that is not directed to mitochondria may be used to metallate
non-heme iron enzymes of the cytosol and nucleus, to assemble
cytosolic Fe–S clusters, or be stored and sequestered in ferritin. The
various fates of cytosolic iron are likely determined by the activ-
ity of iron transporters, such as the mitochondrial iron importers
(Mitoferrin 1 and Mitoferrin 2, Shaw et al., 2006) and iron efﬂux
pumps on the lysosomal or plasma membrane (e.g., ferroportin,
Abboud andHaile, 2000; Donovan et al., 2000; McKie et al., 2000).
Iron storage in ferritin is largely determined by the level of ferritin
protein, which is tightly regulated according to cellular iron lev-
els (reviewed in Anderson et al., 2012). The partitioning of iron to
iron-binding small molecules and proteins of the LIP and proteins
specialized for the delivery of iron cofactors to recipient apoen-
zymes play important roles in determining the fate of cytosolic
iron.
COMPOSITION OF THE CYTOSOLIC LABILE IRON POOL
From a conceptual standpoint, the cytosol must contain a kinet-
ically labile, metabolically accessible pool of iron so that iron can
be distributed to its various sites of utilization, transport, or stor-
age (reviewed in Hider and Kong, 2013). Technical hurdles have
hampered the study of the LIP largely because of the need to study
the pool in intact, living cells. Breaking open cells, diluting their
contents, and exposing the contents to oxygen will greatly alter the
character of the LIP. From a practical standpoint, the measurable
LIP is deﬁned as the pool of iron that is accessible to weak iron
chelators introduced to the cytosol (Petrat et al., 2002). Fluorescent
iron chelators are used to measure the LIP (Esposito et al., 2002).
Chemically, these compounds are composed of a ﬂuorescein moi-
ety conjugated to an Fe(II)- or Fe(III)-binding moiety. These
chelators are introduced to cells as a lipophilic, esteriﬁed precursor,
which is then hydrolyzed and trapped in the cytosol. Iron binding
quenches ﬂuorescence; when a cell-permeable, strong iron chela-
tor is then added, iron shifts from the ﬂuorescent chelator to the
strong chelator and ﬂuorescence is regained. The ratio of ﬂuores-
cence after and before addition of the strong iron chelator provides
an estimate of the chelatable iron pool. Using this approach, the
cytosolic LIP has been measured with calcein and found to be
0.3–1.6 μM, with different cell types exhibiting different baseline
levels of the LIP and different responses to iron-supplemented or
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iron-depleted medium. Measurements using Phen Green-SK sug-
gest higher levels for the cytosolic LIP, which is consistent with
the much higher afﬁnity of Phen Green-SK for Fe (II). Measure-
ments with more iron-speciﬁc ﬂuorescent chelators also indicate
the LIP to be in the low micromolar range. Intracellular iron
species in whole cells have also been measured using spectro-
scopic methods. Human Jurkat cells grown in iron-supplemented
medium were found to contain ∼30 μM high-spin Fe(II) in the
cytosol, a portion of which likely represents the LIP, with the
remainder coordinated by non-heme iron enzymes (Jhurry et al.,
2013).
Attempts have been made to characterize the molecular com-
position of the cytosolic LIP and some progress has been made.
Several approaches based upon the relative binding of iron species
to Fe(II)- and Fe(III)-speciﬁc chelators before and after treatment
with reductants or oxidants indicate that>80–90% of the cytoso-
lic LIP is in the reduced state (Egyed and Saltman, 1984; Breuer
et al., 1995). Using Mossbauer and electron paramagnetic reso-
nance spectroscopy, the cytosolic iron pool of mammalian cells
was found to contain high-spin Fe(III) signals typical of ferritin
and Fe(II) signals in the form of heme and non-heme iron (Jhurry
et al., 2013). This predominance of Fe(II) is consistent with the
presence of excess reduced glutathione andNADPH in the cytosol,
both of which can act as physiologic iron reductants at the pH and
ionic strength of the cytosol. Furthermore, all known metazoan
iron uptake systems are speciﬁc for Fe(II). Thus, the iron initially
entering the cytosol is also in the reduced state.
GLUTATHIONE AS A MAJOR CYTOSOLIC LIGAND FOR Fe(II)
Because the cytosolic LIP is essentially present as Fe(II), the
physiologic ligands for the cytosolic LIP must have afﬁnity for
Fe(II). Many small molecules proposed as physiologic ligands
are unlikely to form complexes with cytosolic iron because they
form stable complexes with Fe(III) and not Fe(II). These would
include ATP/AMP, free amino acids, inositol triphosphates (Veiga
et al., 2009), and 2,5 dihydroxybenzoic acid (Devireddy et al.,
2010; Shvartsman and Ioav Cabantchik, 2012). Candidates for
physiologic Fe(II) ligands include citrate, cysteine, and reduced
glutathione (GSH). Analysis of these potential ligands in vitro
suggests that Fe–GSH complexes are likely the only species that
forms at signiﬁcant levels in cells, largely because GSH is present
at relatively high (2–10 mM) levels in the cytosol and exhibits
moderate afﬁnity (Kd∼8 μM) for Fe(II) (Hider and Kong, 2011).
Other ligands that demonstrate strong afﬁnities for Fe(II) may
not form complexes because they are present at low concen-
trations in the cytosol. Genetic studies in yeast support an
important role of Fe-GSH complexes in the LIP. In yeast cells
engineered to overexpress a GSH importer, GSH overload was
associated with activation of the iron-sensing transcription fac-
tor Aft1 and impaired activity of a cytosolic iron–sulfur cluster
enzyme (Kumar et al., 2011). Depletion of cellular GSH by dele-
tion of the essential γ-glutamylcysteine synthetase also led to Aft1
activation and impaired cytosolic Fe–S cluster enzyme activity,
which could be partially restored with exogenous iron (Sipos et al.,
2002; Kumar et al., 2011); neither of these phenotypes was due to
oxidative stress or damage. These studies point to Fe–GSH com-
plexes as having a critical role in maintaining iron distribution
and homeostasis in eukaryotic cells. Additional studies indicate
that Fe–GSH, in conjunction with monothiol glutaredoxins, has
a direct role in the formation and transfer of cytosolic Fe–S
clusters.
PROTEINS INVOLVED IN CYTOSOLIC IRON DISTRIBUTION:
MONOTHIOL GLUTAREDOXINS
In addition to its role as a ligand in the cytosolic LIP, GSH
coordinates iron as part of the Fe–S carrier complex formed by
cytosolic monothiol glutaredoxins (reviewed in Rouhier et al.,
2010). The glutaredoxins are a ubiquitous class of enzyme with
a thioredoxin fold and are generally thought to function as thiol-
disulﬁde oxidoreductases with roles in glutathione conjugation.
These enzymes contain one or two cysteine residues in their
active site that are critical for enzymatic activity. A subset of
the glutaredoxin family does not exhibit oxidoreductase activity
and contains a monothiol active site motif that consists of the
tetrapeptide CGFS. These monothiol glutaredoxins instead func-
tion as Fe–S cluster carriers. Eukaryotic cells contain separate
monothiol glutaredoxins that localize to either the mitochon-
dria (Grx5) or the cytosol (Grx3/4). Grx5 plays an important
role in the assembly and transfer of Fe–S clusters in mitochon-
dria (Rodriguez-Manzaneque et al., 2002; Wingert et al., 2005; Ye
et al., 2010). Yeast, ﬁsh, and human cells lacking Grx5 exhibit
profound defects in the assembly of both mitochondrial and
cytosolic Fe–S clusters. Recent evidence suggests that cytosolic
Grx3-type glutaredoxins may have a broader role in cytosolic iron
distribution.
Structurally, Grx3-type glutaredoxins have a single N-terminal
thioredoxin domain and 1–3 C-terminal glutaredoxin domains
(Rouhier et al., 2010). The functionally interchangeable Grx3 and
Grx4 of yeast contain a single CGFS glutaredoxin domain while
the sole human ortholog, Grx3 (also called Glrx3 and PICOT),
contains two. In vitro, Grx3 forms homodimers that can accom-
modate a bridging [2Fe−2S] cluster, which is coordinated by the
single active site cysteine present in each monomer and by the free
sulfhydryl on each of two molecules of GSH. The cluster is labile,
sensitive to both reductants and oxidants, and can be transferred
to a recipient Fe–S scaffold protein (Li et al., 2009; Haunhorst et al.,
2010).
In many species, including prokaryotes, plants, yeast, and
metazoans, monothiol glutaredoxins may be found in com-
plex with BolA-like proteins, with distinct complexes formed in
the cytosol/nucleus, mitochondria, and plastids. In vitro, Grx3
domains can form heterooligomers with the yeast and human
cytosolic BolA2-type proteins in a 1:1 stoichiometric ratio. These
complexes also coordinate bridging [2Fe−2S] clusters, with BolA2
contributing a histidine ligand to coordinate the cluster(s) (Li
et al., 2011). Clusters formed on Grx3–BolA2 complexes exhibit
more stability than those formed on Grx3 homodimers, and Grx3
homodimers will spontaneously transfer a [2Fe−2S] cluster to
Grx3–BolA2 in vitro (Li et al., 2009).
Genetic studies in yeast, ﬁsh, and human cells suggest that
Grx3 orthologs have similar but distinct roles in cytosolic iron
delivery. In yeast, assembly of Fe–S clusters on Grx4 requires the
cytosolic Fe–S assembly machinery, but it is not dependent on the
remaining cytosolic Fe–S cluster machinery. Although Grx3/4 is
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expressed in the cytosol and nucleus, their activities affect iron
handling in both the cytosol and mitochondria. Strains lacking
Grx3/4 exhibit defects in the incorporation of iron–sulfur clusters
into mitochondrial Fe–S enzymes (ﬁvefold decrease in aconitase),
defects in the incorporation of iron into heme (ﬁvefold decrease),
and reduced accumulation of iron into mitochondria (2.3-fold
decrease). These observations are all consistent with a defect
in mitochondrial iron delivery. In the cytosol, Grx3/4-deﬁcient
strains also exhibit reduced metallation of Fe–S enzymes (four to
tenfold decrease). Furthermore, a cytosolic dinuclear iron enzyme,
ribonucleotide reductase, also appears to require Grx3/4 for acqui-
sition of iron (Muhlenhoff et al., 2010). This study suggests that
Grx3/4 has roles in the delivery of iron to mitochondria and to
cytosolic non-heme enzymes as well as in the delivery or assembly
of Fe–S clusters.
Grx3-type glutaredoxins from several species have been found
to interact with BolA-like proteins in vivo. In yeast, Grx3/4 and
Fra2, the cytosolic BolA ortholog, have been found together in a
complex with Aft1, the major iron-dependent transcription fac-
tor (Kumanovics et al., 2008). Grx3/4−Fra2 complexes appear
to have a specialized regulatory function in yeast, as both are
required for the sensing of iron (Ojeda et al., 2006; Pujol-Carrion
et al., 2006) and can mediate the transfer of a [2Fe−2S] cluster
to the Aft1 paralog, Aft2 (Poor et al., 2014). Zebraﬁsh contain
a single Grx3 ortholog, which could be depleted in embryos
through morpholino injection. Zebraﬁsh embryos lacking Grx3
exhibited severe defects in heme synthesis in tissues devoted to
embryonic erythropoiesis (38%of embryos exhibited hemoglobin
staining), but mild defects in the activities of Fe–S cluster and
heme enzymes (20% decrease). In human cells, knockdown of
Grx3 was associated with loss of Fe–S cluster-dependent, cytoso-
lic aconitase activity (60% decrease) and concomitant disruption
of cellular iron homeostasis. In contrast, activities of mito-
chondrial heme enzymes and heme synthesis were only mildly
diminished (20% decrease, Haunhorst et al., 2013). Thus, in
vertebrates, Grx3 may be important for iron delivery to mito-
chondria primarily in erythropoietic tissues, which have very high
requirements for iron. Grx3 may also be involved in cytosolic
Fe–S cluster delivery or assembly. Although in vitro studies have
demonstrated that Grx3–Fra2 complexes can donate a [2Fe−2S]
cluster to Aft2, and genetic studies in yeast support this evi-
dence of a direct Fe–S transfer to Aft1, studies have not yet
made clear whether Grx3-type homodimers directly deliver Fe–S
clusters or iron ions to targets in yeast or human cells. Simi-
larly, the role of Fra2/BolA2 in human cells is largely unknown,
although the mitochondrially targeted BolA3 is involved in Fe–S
cluster acquisition and/or maintenance for some mitochondrial
Fe–S enzymes, especially lipoate synthase (Cameron et al., 2011;
Haack et al., 2013; Baker et al., 2014). The mechanism by which
Grx3 acquires iron is also not yet known, but it appears not
to require the activity of the cytosolic Fe–S cluster assembly
system.
PROTEINS INVOLVED IN CYTOSOLIC IRON DISTRIBUTION:
PCBPs
The term metallochaperone has been used to describe proteins
that directly deliver metals to target enzymes or transporters
through metal-mediated protein–protein interactions (Lee et al.,
1993; Culotta et al., 1997; Pufahl et al., 1997). Iron chaperone activ-
ity has been demonstrated for the poly C binding protein (PCBP)
family of proteins (Shi et al., 2008). PCBP1 was initially identi-
ﬁed as an iron chaperone for ferritin, the ubiquitous iron storage
protein. Ferritin, composed of 24 subunits of H- and L-isoforms,
functions as a cellular repository of surplus iron by accommodat-
ing up to 4500 iron atomswithin its spherical core. Delivery of iron
atoms into the hollow sphere of ferritin occurs via the hydrophilic
channels formed by the carboxylate side chains along the threefold
symmetry axes in the heteropolymer. Initially, ferritin accrues iron
atoms in the ferrous form,which are then oxidized to ferric iron by
the ferroxidase center of H-ferritin, located in the interior of the
ferritin cavity (reviewed in Arosio and Levi, 2010). Even though
the regulatory mechanisms of this gene product have been exten-
sively studied under various physiological conditions, the cytosolic
trafﬁcking system directing iron to the metalloprotein had been
elusive until the recent discovery of the iron chaperone activity of
PCBP1.
The role of PCBP1 in the mineralization of ferritin was ini-
tially identiﬁed through functional screening of a human liver
cDNA library in a eukaryotic model lacking endogenous ferritin
expression, i.e., Saccharomyces cerevisiae (Shi et al., 2008). Co-
expression of human ferritins and PCBP1 in yeast cells produced
an iron deﬁciency response, implying sequestration of cellular
iron into the exogenous iron storage protein. This was conﬁrmed
by measuring PCBP1-dependent increases in ferritin iron con-
tent. The requirement of endogenous PCBP1 in mammalian cells
was shown by loss-of-function experiments using cultured human
Huh7 cells. RNA interference of PCBP1 led to inefﬁcient min-
eralization of ferritin (63% reduction) along with increases in
iron-mediated degradation of iron-regulatory protein 2 (IRP2)
and in the cellular LIP (67% increase). In vitro experiments with
puriﬁed PCBP1 and ferritin supported the direct involvement
of PCBP1 in the mineralization of ferritin by a dose-dependent
enhancement in the incorporation of iron into apoferritin by the
chaperone protein.
PCBP1 [also known as heterogeneous nuclear ribonucleopro-
tein (hnRNP) E1 or α-CP1] is a member of the poly(rC)-binding
protein family, composed of four homologous proteins of which
others are PCBP2, PCBP3, and PCBP4. PCBPs were initially
characterized as RNA-binding proteins, modulating the stability
or translation of cellular and viral RNA species containing C-
rich motifs (Makeyev and Liebhaber, 2002; Ostareck-Lederer and
Ostareck, 2004; Chaudhury et al., 2010). Other regulatory func-
tions include their involvement in transcriptional regulation of
gene expression and protein–protein interactions. PCBPs contain
three highly conserved hnRNPK homology (KH) domains, which
are ancient, RNA-binding motifs broadly distributed in prokary-
otes and eukaryotes. Sequences outside of the KH domains exhibit
much less conservation. PCBP1 and PCBP2 are expressed at high
levels in essentially all mammalian cell types, while PCBP3 and
PCBP4 exhibit much lower levels of expression in a limited range
of tissues. PCBP1 is speciﬁc to mammals, while genes orthol-
ogous to those of PCBP2, 3, and 4 are present in vertebrates,
ﬂies, and worms, and distantly related orthologs are present in
yeast.
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Recently, PCBP2 was also identiﬁed as an iron chaperone
for ferritin, conferring increased iron storage when co-expressed
in yeast and manifesting decreased iron storage when depleted
from human Huh7 cells (Leidgens et al., 2013). PCBP3 could
also induce iron deﬁciency responses in yeast by enhancing the
sequestration of iron into exogenously expressed ferritin. Notably,
the presence of KH domains alone was not sufﬁcient for con-
ferring iron delivery activity to PCBPs, as a splice variant of
PCBP3 lacking 26 amino acids between KH domains 2 and 3 and
an unrelated RNA-binding protein containing two KH domains
(fragile X mental retardation 1) had essentially no iron activity
in yeast cells. PCBP4 also activates the iron deﬁciency response
in yeast, but it shows weak genetic and physical interactions
with ferritin. PCBP4 could function as a buffer for labile iron
or could be involved in organellar iron delivery in specialized cell
types.
Puriﬁed recombinant PCBP1 and PCBP2 were found to
bind ferrous iron in vitro using isothermal titration calorime-
try (ITC). ITC characterizes the thermodynamic properties of
a ligand binding reaction, and thus allows a quantitative mea-
surement of both binding afﬁnity and stoichiometry. Anaerobic
titration of ferrous iron into puriﬁed PCBP1 revealed an iron-
binding capacity of three ferrous iron atoms per molecule of
PCBP1, with a dissociation constant of 0.9 ± 0.1 μM for
the ﬁrst and an average of 5.8 ± 0.3 μM for the remain-
ing two (Shi et al., 2008). PCBP2 exhibits similar iron-binding
characteristics (T. Stemmler, personal communication). Physi-
cal interactions between PCBP1, PCBP2, and ferritin were also
measured using ITC (Leidgens et al., 2013). Puriﬁed PCBPs exhib-
ited no signiﬁcant interaction with ferritin in the absence of iron.
However, PCBP1 and PCBP2, anaerobically loaded with ferrous
iron, exhibited afﬁnities for apoferritin that were 30- and 20-
fold higher, respectively, than the afﬁnity of free ferrous iron
for ferritin. Approximately, nine Fe-PCBP1 molecules bind to a
ferritin oligomer. As the number of putative iron delivery chan-
nels is eight per ferritin polymer, this stoichiometry supports a
model of PCBP1 facilitating iron incorporation into ferritin via
direct binding at pores formed by the threefold axes of symme-
try. Fe-PCBP2 binds to ferritin in a stoichiometric ratio of 4:1
Fe-PCBP2:ferritin.
In human cells, PCBP1, PCBP2, and PCBP3 can be isolated
in complexes with ferritin (Leidgens et al., 2013). PCBP1 and
PCBP2 are also found to interact with each other, both in yeast
and human cells. Two lines of evidence suggest that PCBP1 and
PCBP2may act together in iron delivery. First, Huh7 cells depleted
of PCBP1 or PCBP2 contain wild-type levels of the other paralog,
yet exhibit marked defects in ferritin iron loading. The simultane-
ous depletion of both PCBP1 and PCBP2 produces an iron storage
defect similar in magnitude to the single deletion of either. These
observations indicate that PCBP1 cannot substitute for PCBP2 in
human cells and vice versa. Second, quantitative immunoprecip-
itation studies indicate that the interaction between ferritin and
PCBP1 is diminished when PCBP2 is depleted; similarly, the co-
precipitation of PCBP2with ferritin is diminished in cells depleted
of PCBP1. These observations suggest that PCBP1 and PCBP2
function cooperatively, perhaps as a complex, in the distribution
of iron.
METALLATION OF NON-HEME IRON ENZYMES
In addition to ferritin, PCBPs exhibit iron chaperone activity
toward other cytosolic iron enzymes. The class of iron- and 2-
oxoglutarate (2-OG)-dependent dioxygenases comprises a large
family of non-heme iron enzymes that require the incorpora-
tion of a single iron atom into its active site for activation (Ozer
and Bruick, 2007; Loenarz and Schoﬁeld, 2008). Recently, two of
these mononuclear iron enzymes, prolyl hydroxylase 2 (PHD2)
and the asparaginyl hydroxylase, factor inhibiting HIF1 (FIH1),
have been identiﬁed as clients for iron delivery by PCBPs (Nandal
et al., 2011).
Hypoxia-inducible factors (HIF) are heterodimeric transcrip-
tion factors that mediate the cellular adaptation to hypoxia
(Semenza, 2007; Kaelin and Ratcliffe, 2008). Conditions of
reduced oxygen lead to the accumulation of the alpha sub-
units (HIFα), HIF1α and HIF2α, which assemble into the active
form with its constitutively expressed counterpart, HIF1β. In
normoxia or hyperoxia, PHD hydroxylates HIFα on proline
residues within the highly conserved oxygen-dependent degra-
dation domains. Upon recognition by the von Hippel-Lindau
(VHL) tumor suppressor protein, hydroxylated HIFα undergo
proteolysis via the ubiquitin-proteasome pathway. FIH1 also reg-
ulates HIFα via hydroxylation of a conserved amino acid, in this
case, however, at asparagine. The hydroxylation at the asparaginyl
residue blocks the interaction of the alpha subunits with coactiva-
tors and thus results in the inactivation of HIF. In the absence
of oxygen, a co-substrate for both enzymes, HIFα subunits
remain unmodiﬁed and can accumulate and assemble into active
heterodimers.
The activities of the oxygen-sensing HIF hydroxylases are also
responsive to the availability of iron. Treatment of cells with
supplemental iron results in an increase in the HIF hydroxylase
activity, while iron chelation produces the opposite effect (Kaelin
and Ratcliffe, 2008). Moreover, induction of HIF2 signaling has
been reported in the small intestine of mice subjected to dietary
iron deﬁciency, which may be attributable to compromised HIF
hydroxylase activity (Shah et al., 2009). While the requirement of
iron for HIF hydroxylase activation has been known for several
decades, the mechanism which mediates the incorporation of a
mononuclear iron center into the apoenzyme remained unknown
until recent studies implicated the involvement of PCBPs.
Cultured human cells lacking PCBP1 or PCBP2 exhibit nuclear
accumulationof activeHIF1α, which increases in cellsmademildly
or transiently iron deﬁcient (Nandal et al., 2011). Loss of PCBP
expression leads to prolonged HIF1α half-life without altering
steady-state levels of HIF1α transcripts. The responses of HIF1α to
PCBP1 or PCBP2 depletion are due to the inactivation of PHD2,
which accounts for nearly all of the prolyl hydroxylation of HIF1α
in cells (Berra et al., 2003). Cells depleted of PCBP1, PCBP2, or
both exhibit reduced incorporation of the iron cofactor into PHD2
(20–40% of control) and complete loss of enzyme activity in cell
lysates. In lysates, the effects of PCBP depletion on PHD activity
can be reversed by exogenous addition of excess iron. As for the
case of ferritin, PCBP1 can form complexes with PHD2 in human
cells. Thus, the PCBP-mediated delivery of iron into the active site
of the mononuclear iron enzyme is likely accomplished via direct
protein–protein interaction.
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The activity of FIH1, also an iron- and oxygen-dependent
HIF1α regulator, is dependent on PCBP1 as well (Nandal et al.,
2011). Cells depleted of PCBP1 exhibit increased expression of
a reporter construct repressed by FIH1, and FIH1 was detected
in a complex with PCBP1 in iron-treated cells. The loss of FIH1
activity and the physical interaction between cellular PCBP1 and
FIH1 suggest that FIH1 is also a target for iron delivery by PCBP1.
Whether all iron- and 2-OG-dependent enzymes require PCBPs
for their metallation and activation remains undetermined.
Other classes of iron metalloenzymes may also depend on iron
delivery by PCBPs. Of particular interest are the dinuclear, non-
heme iron enymes, someof which contain iron-binding active sites
structurally related the ferroxidase site of ferritin, a known target
of PCBPs. Examples of this class of enzymes are the small sub-
unit of ribonucleotide reductase (Stubbe and Cotruvo, 2011) and
deoxyhypusine hydroxylase (DOHH, Vu et al., 2009). DOHH is a
dinuclear iron enzyme that is required for the posttranslational
modiﬁcation of a single lysine residue on eukaryotic initiation
factor 5A (eIF5A, Park et al., 2010). EIF5A and the conversion of
this conserved lysine to hypusine are essential in all eukaryotes,
as it enables the translation of peptides containing polyproline
sequences (Gutierrez et al., 2013). Cells lacking PCBP1 or PCBP2
exhibit loss of DOHH activity, as measured by the accumulation
of partially modiﬁed deoxyhypusine and reduced levels of fully
modiﬁed hypusine (20% of control) in living cells. DOHH from
PCBP-depleted cells also exhibits loss of the iron cofactor when
the cells are exposed to mild iron deﬁciency. As for other PCBP
targets, DOHH is detected in a complex with PCBP1, indicating
their direct association during the assembly of the diiron active
site. PCBPs do not appear to be required for iron delivery to mito-
chondria or for the de novo assembly of iron–sulfur clusters in
the cytosol (Frey et al., 2014). Collectively, PCBPs can regulate the
cellular distribution of labile iron by depositing it into the cellular
iron reservoir ferritin and/or by directing it to the site of utilization
as an inorganic cofactor for cytosolic non-heme iron enzymes.
ROLE OF PCBPs IN REGULATION OF IRON HOMEOSTASIS
The iron chaperone activities of PCBPs do not appear to be regu-
lated in response to changing cellular iron availability. That is, the
expression level and iron-binding activity do not appear to change
under different iron conditions (Frey et al., 2014). Although inter-
actionswith client enzymes do appear, in some cases, to be lessened
when iron is scarce, this effect could bemediated solely by the less-
ened stability of the chaperone–client interaction in the absence
of bound iron. PCBPsmay, however, inﬂuence cellular iron home-
ostasis through their iron chaperone activities. Huh7 cells depleted
of PCBPs store less cytosolic iron in ferritin, thereby expanding
the LIP (Shi et al., 2008). This expansion of the LIP is reﬂected in
lowered levels of iron regulatory protein 2 (IRP2), which under-
goes ubiquitin-mediated degradation in the presence of increased
labile iron (Guo et al., 1995). Whether the degradation associated
with PCBP depletion is dependent on the recently described ubiq-
uitin ligase FBXL5 has not been determined (Salahudeen et al.,
2009; Vashisht et al., 2009). HEK 293T cells depleted of PCBPs
exhibit reduced activity of cytosolic (c-) aconitase (Frey et al.,
2014), an enzyme that carries a labile [4Fe-4S] cluster in its active
site. C-aconitase, also called iron regulatory protein 1 (IRP1), is
a bifunctional enzyme because it acquires RNA-binding activity
when the [4Fe-4S] cluster is absent (reviewed in Anderson et al.,
2012). Together, IRP1 and IRP2 regulate cellular iron uptake and
storage by altering the translation and stability of mRNA tran-
scripts that contain iron-responsive elements (IREs) in the 5′ or 3′
UTR. These transcripts encode proteins of iron uptake, e.g., trans-
ferrin receptor and divalentmetal transporter 1 (DMT1), and iron
storage, e.g., ferritin. Although PCBP depletion leads to loss of c-
aconitase activity, it does not appear to lead to a reciprocal increase
in IRE-binding activity, suggesting that PCBP depletion does not
result in the complete disassembly of the Fe–S cluster in IRP1. In
fact, PCBP depletion was associated with loss of IRP1-mediated
IRE binding activity. Thus, loss of cellular PCBPs results in loss of
IRP1- and IRP2-mediated IRE-binding activity, which likely pro-
duce misregulation of proteins that maintain the iron balance of
the cytosol.
Tissues may also exhibit speciﬁc requirements for PCBPs in the
delivery of iron. In mice, dietary iron deﬁciency leads to increased
HIF2α in intestinal epithelial cells, where it promotes the tran-
scription of DMT1 and other genes involved in the absorption
of dietary iron (Mastrogiannaki et al., 2009; Shah et al., 2009).
Intestinal HIF2α is likely regulated by prolyl and asparagyl hydrox-
ylases, which receive iron cofactors from PCBP1 and PCBP2.
Thus, PCBPs may be important for the response to iron deﬁ-
ciency in gut cells. Recently, H-ferritin was determined to be
an indispensible factor for accurately controlling intestinal iron
absorption, primarily by retaining iron in absorptive enterocytes
and preventing excessive iron transfer from enterocytes to the
systemic circulation (Vanoaica et al., 2010). Loss of H-ferritin
expression in the small intestine led to characteristic manifes-
tations of hemochromatosis. The perturbation in systemic iron
homeostasis was attributed to higher systemic absorption of iron
due to enhanced efﬂux from enterocytes through the basolateral
transporter, ferroportin 1. Dysfunction of the iron storage pro-
tein also affected cellular iron homeostasis in the enterocytes. It
is not yet known whether PCBPs mediate ferritin iron loading in
the intestinal enterocyte, but if enterocytes do rely on PCBPs, they
may also serve as a limiting component for body iron accrual by
directing and loading the metal to ferritin. In addition to these
indirect effects on iron uptake, storage and efﬂux, PCBPs may
exert direct effects on transport. A recent report indicates that
PCBP2 directly interacts with both DMT1 and ferroportin in cells,
enhancing the transport of iron via DMT1 (Yanatori et al., 2014).
Other cell types, such as macrophages and erythropoietic cells
have special requirements for iron handling, as they accommo-
date the large iron ﬂuxes associated with the recycling of iron from
senescent red blood cells and hemoglobin synthesis, respectively.
Whether PCBPs play a role in these processes remains to be deter-
mined. An important consideration in these studies is the kinetics
involved in the intracellular iron delivery systems.What is the time
frame for delivery of iron and metallation of enzymes in the cell?
New approaches will be required to address these types of ques-
tions. In summary, PCBPs may provide strategies for the efﬁcient
management of the newly acquired or mobilized iron atoms by
efﬁciently delivering them to their appropriate destination, partic-
ularly in cell types that routinely encounter dynamic changes in the
cytosolic LIP.
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